Tribbles-1 and -2 are tumour suppressors, down-regulated in human acute myeloid leukaemia

Immunology Letters

Volumn 130, Issue 1-2, 2010, Pages 115-124

  Gilby, Daniel C ^a   Sung, Hye Youn ^a   Winship, Peter R ^a   Goodeve, Anne C ^a   Reilly, John T ^a   Kiss Toth, Endre ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Leukaemia; Monocytes; Tribbles

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MESSENGER RNA; PROTEIN BCL 2; REGULATOR PROTEIN; SERINE; STRESS ACTIVATED PROTEIN KINASE; TRIBBLE 1 PROTEIN; TRIBBLE 2 PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; AUTOREGULATION; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INACTIVATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CHILD, PRESCHOOL; DOWN-REGULATION; FEMALE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MYELOID, ACUTE; MALE; PROTEIN ARRAY ANALYSIS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; YOUNG ADULT;

EID: 77950951853     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.12.007     Document Type: Article

References (46)

1. Towatari M., Iida H., Tanimoto M., Iwata H., Hamaguchi M., Saito H. Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 1997, 11:479-484.
2. Zheng R., Levis M., Piloto O., Brown P., Baldwin B.R., Gorin N.C., et al. FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells. Blood 2004, 103:267-274.
3. Kiyoi H., Towatari M., Yokota S., Hamaguchi M., Ohno R., Saito H., et al. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product. Leukemia 1998, 12:1333-1337.
4. Hartman A.D., Wilson-Weekes A., Suvannasankha A., Burgess G.S., Phillips C.A., Hincher K.J., et al. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation. Exp Hematol 2006, 34:1360-1376.
5. Cripe L.D., Gelfanov V.M., Smith E.A., Spigel D.R., Phillips C.A., Gabig T.G., et al. Role for c-jun N-terminal kinase in treatment-refractory acute myeloid leukemia (AML): signaling to multidrug-efflux and hyperproliferation. Leukemia 2002, 16:799-812.
6. Eder K., Guan H., Sung H.Y., Ward J., Angyal A., Janas M., et al. Tribbles-2 is a novel regulator of inflammatory activation of monocytes. Int Immunol 2008, 20:1543-1550.
7. Sung H.Y., Guan H., Czibula A., King A.R., Eder K., Heath E., et al. Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. J Biol Chem 2007, 282:18379-18387.
8. Hegedus Z., Czibula A., Kiss-Toth E. Tribbles: a family of kinase-like proteins with potent signalling regulatory function. Cell Signal 2007, 19:238-250.
9. Hegedus Z., Czibula A., Kiss-Toth E. Tribbles: novel regulators of cell function; evolutionary aspects. Cell Mol Life Sci 2006, 63:1632-1641.
10. Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C., Caunt J.C., et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 2004, 279:42703-42708.
11. Sharova L.V., Sharov A.A., Nedorezov T., Piao Y., Shaik N., Ko M.S. Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res 2008.
12. Sung H.Y., Francis S.E., Crossman D.C., Kiss-Toth E. Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific. Immunol Lett 2006, 104:171-177.
13. Mata J., Curado S., Ephrussi A., Rorth P. Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis. Cell 2000, 101:511-522.
14. Grosshans J., Wieschaus E. A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila. Cell 2000, 101:523-531.
15. Perotti C., Wiedl T., Florin L., Reuter H., Moffat S., Silbermann M., et al. Characterization of mammary epithelial cell line HC11 using the NIA 15k gene array reveals potential regulators of the undifferentiated and differentiated phenotypes. Differentiation 2009.
16. Jin G., Yamazaki Y., Takuwa M., Takahara T., Kaneko K., Kuwata T., et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood 2007, 109:3998-4005.
17. Storlazzi C.T., Fioretos T., Surace C., Lonoce A., Mastrorilli A., Strombeck B., et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 2006, 15:933-942.
18. Storlazzi C.T., Fioretos T., Paulsson K., Strombeck B., Lassen C., Ahlgren T., et al. Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignancies. Hum Mol Genet 2004, 13:1479-1485.
19. Rothlisberger B., Heizmann M., Bargetzi M.J., Huber A.R. TRIB1 overexpression in acute myeloid leukemia. Cancer Genet. Cytogenet 2007, 176:58-60.
20. Mrozek K. Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol 2008, 35:365-377.
21. Puigdecanet E., Espinet B., Lozano J., Sumoy L., Bellosillo B., Arenillas L., et al. Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia. Leukemia 2008.
22. Puskas L.G., Juhasz F., Zarva A., Hackler L.J., Farid N.R. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Cell Mol Biol (Noisy-le-grand) 2005, 51:177-186.
23. Puiffe M.L., Le Page C., Filali-Mouhim A., Zietarska M., Ouellet V., Tonin P.N., et al. Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer. Neoplasia 2007, 9:820-829.
24. Keeshan K., He Y., Wouters B.J., Shestova O., Xu L., Sai H., et al. Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia. Cancer Cell 2006, 10:401-411.
25. Keeshan K., Shestova O., Ussin L., Pear W.S. Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia. Blood Cells Mol Dis 2008, 40:119-121.
26. Argiropoulos B., Palmqvist L., Yung E., Kuchenbauer F., Heuser M., Sly L.M., et al. Linkage of Meis1 leukemogenic activity to multiple downstream effectors including Trib2 and Ccl3. Exp Hematol 2008, 36:845-859.
27. Lin K.R., Lee S.F., Hung C.M., Li C.L., Yang-Yen H.F., Yen J.J. Survival factor withdrawal-induced apoptosis of TF-1 cells involves a TRB2-Mcl-1 axis-dependent pathway. J Biol Chem 2007, 282:21962-21972.
28. Xu J., Lv S., Qin Y., Shu F., Xu Y., Chen J., et al. TRB3 interacts with CtIP and is overexpressed in certain cancers. Biochim Biophys Acta 2007, 1770:273-278.
29. Bowers A.J., Scully S., Boylan J.F. SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in human tumors and is regulated by hypoxia. Oncogene 2003, 22:2823-2835.
30. Ohoka N., Yoshii S., Hattori T., Onozaki K., Hayashi H. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 2005, 24:1243-1255.
31. Qian B., Wang H., Men X., Zhang W., Cai H., Xu S., et al. TRIB3 is implicated in glucotoxicity- and oestrogen receptor-stress-induced β-cell apoptosis. J Endocrinol 2008, 199:407-416.
32. Zou C.G., Cao X.Z., Zhao Y.S., Gao S.Y., Li S.D., Liu X.Y., et al. The molecular mechanism of endoplasmic reticulum stress-induced apoptosis in PC-12 neuronal cells: the protective effect of insulin-like growth factor I. Endocrinology 2009, 150:277-285.
33. Valk P.J., Verhaak R.G., Beijen M.A., Erpelinck C.A., Barjesteh van Waalwijk van Doorn-Khosrovani S., Boer J.M., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 350:1617-1628.
34. Verhaak R.G., Goudswaard C.S., van Putten W., Bijl M.A., Sanders M.A., Hugens W., et al. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005, 106:3747-3754.
35. Deng X., Ruvolo P., Carr B., May W.S.J. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc Natl Acad Sci USA 2000, 97:1578-1583.
36. Ruvolo P.P., Deng X., Carr B.K., May W.S. A functional role for mitochondrial protein kinase Cα in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 1998, 273:25436-25442.
37. Ito T., Deng X., Carr B., May W.S. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Chem 1997, 272:11671-11673.
38. Mueller B.U., Pabst T. C/EBPα and the pathophysiology of acute myeloid leukemia. Curr Opin Hematol 2006, 13:7-14.
39. Stirewalt D.L., Meshinchi S., Kopecky K.J., Fan W., Pogosova-Agadjanyan E.L., Engel J.H., et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer 2008, 47:8-20.
40. Tran T.H., Andreka P., Rodrigues C.O., Webster K.A., Bishopric N.H. Jun kinase delays caspase-9 activation by interaction with the apoptosome. J Biol Chem 2007, 282:20340-20350.
41. Yu C., Minemoto Y., Zhang J., Liu J., Tang F., Bui T.N., et al. JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 2004, 13:329-340.
42. Ziegler K., Kurz C.L., Cypowyj S., Couillault C., Pophillat M., Pujol N., et al. Antifungal innate immunity in C. elegans: PKCδ links G protein signaling and a conserved p38 MAPK cascade. Cell Host Microbe 2009, 5:341-352.
43. Malik K.T., Poirier V., Ivins S.M., Brown K.W. Autoregulation of the human WT1 gene promoter. FEBS Lett 1994, 349:75-78.
44. Sassone-Corsi P., Sisson J.C., Verma I.M. Transcriptional autoregulation of the proto-oncogene fos. Nature 1988, 334:314-319.
45. Grignani F., Lombardi L., Inghirami G., Sternas L., Cechova K., Dalla-Favera R. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J 1990, 9:3913-3922.
46. Wang X., Li Z., Naganuma A., Ye B.H. Negative autoregulation of BCL-6 is bypassed by genetic alterations in diffuse large B cell lymphomas. Proc Natl Acad Sci USA 2002, 99:15018-15023.